Добро пожаловать
Нажатие «Авторизоваться» означает, что вы соглашаетесь с Условия использования и политика конфиденциальности Cointime.
Зарегистрировать аккаунт
Аккаунт уже существует?
Нажатие «page.Sign up» означает, что вы соглашаетесь с <a class="underline" href="#term-of-service">Условия использования</a> и a class="underline" href="#privacy-policy">политика конфиденциальности</a> Cointime.
Войдите, используя email
Зарегистрируйтесь с помощью email
твой почтовый ящик
Проверь свои входящие
Нажмите на ссылку в , чтобы войти.
Нажмите на ссылку в , чтобы зарегистрироваться.
CompleGen
company
About
CompleGen is an early-stage biopharmaceutical company that is applying a proprietary system to discover novel biologically active chemicals.
- 11 - 50
Details
- Last Funding Type
- Grant
- Last Funding Money Raised
- $100K
- Industries
- Biopharma,Biotechnology,Pharmaceutical
- Founded date
- Jan 1, 2002
- Number Of Employee
- 11 - 50
- Operating Status
- Active
CompleGen is an early-stage biopharmaceutical company that is applying a proprietary system to discover novel biologically active chemicals.Their system is used to build compound discovery systems for a broad range of therapeutic targets for the pharmaceutical industry, as well as efficient cost-effective product discovery systems for the agricultural industry.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
1
$100K
CompleGen has raised a total of
$100K
in funding over 2 rounds. Their latest funding was raised on
Mar 15, 2002 from a Grant round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Mar 15, 2002 | Grant | $100K | 1 | — | — | Detail |
Investors
Number of Lead Investors
Number of Investors
—
1
CompleGen is funded by 1 investors.
National Institutes of Health
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
National Institutes of Health
|
— | Grant |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
